 LOS ANGELES--BUSINESS WIRE--Second Sight Medical Products, Inc. NASDAQ: EYES the Company or Second Sight, a leading developer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced that it has closed its previously announced private placement, which resulted in gross proceeds to Second Sight of 27.9 million, before deducting offering expenses. The net proceeds from the private placement are 